Results 81 to 90 of about 22,112 (155)

Identification of Plasma Biomarkers for B7 Family Members Associated With Primary Sjögren's Syndrome. [PDF]

Immun Inflamm Dis
Song S, Yang Y, Shen Y, Ren T, Sun Z, Liu C.   +5 more
europepmc   +1 more source

Natural Killer Cells in Cancer Immunotherapy [PDF]

, 2019
Arndt MA, Chester C, Cortez VS, D'Andrea A, Elsasser D, Ferrini S, Gao Y, Hartmann F, Lotze MT, Miller JS, Orr MT, Seillet C, Soiffer RJ, Soto EO, Weiner LM, Yron I   +15 more
core   +1 more source

Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma. [PDF]

Int J Nanomedicine
Cheng Z, Amin M, van Brakel M, Sacchetti A, Kim RQ, Seynhaeve ALB, Debets R, Ten Hagen TLM.   +7 more
europepmc   +1 more source

Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer. [PDF]

Front Immunol
Brown EF, Colombo I, Madariaga A, Kasherman L.   +3 more
europepmc   +1 more source

Investigating the activation of the immune response by outer membrane vesicles from Bacteroides fragilis using a human gastrointestinal cell system. [PDF]

J Immunol
Jefferis TM, Scano C, Ashraf A, Stevens DM, Sevcik A, Bruce E, Greathouse L, Sayes CM.   +7 more
europepmc   +1 more source

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor [PDF]

, 2014

core   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

Theranostics
Kim RK, Heo CK, Choi MJ, Kahm YJ, Kim MK, Lee M, Lee JY, Park H, Jung U, Shin BC, Kim BJ, Kim SC, Cho EW, Ryu CJ, Kim IG.   +14 more
europepmc   +1 more source

Deletion of Lymphatic PD-L1 Protects Mice From Severe Autoimmune Encephalitis. [PDF]

Eur J Immunol
Wang Z, Meuffels E, Ashworth C, Reynaud E, Hemanna S, Becher B, Detmar M, Mundt S, Dieterich LC.   +8 more
europepmc   +1 more source

Does the B7-H3 Immune Checkpoint Have High Potential as a Therapeutic Target? [PDF]

Cells
Agostini M, Traldi P, Hamdan M.
europepmc   +1 more source

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors [PDF]

, 2010
Céline Berthon, Virginie Driss, Jizhong Liu, Klaudia Kuranda, Xavier Leleu, Nathalie Jouy, Dominique Hetuin, Bruno Quesnel   +7 more
core   +1 more source